Please wait...
About This Project
We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Browse Other Projects on Experiment
Related Projects
Can we biologically extend the range of human vision into the near infrared?
We have developed a protocol to augment human sight to see into the near infrared range through human formation...
Developing a novel oxysterol antibiotic to combat drug-resistant tuberculosis
Drug-resistant tuberculosis (TB) is a consistently growing threat to global health. We have developed Oxy291...
Can Data Management Tools Improve Research Efficiency and Reproducibility?
Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve...